Skip to main content

Primitive Neuroectodermal Tumor clinical trials at UCSF

19 in progress, 8 open to eligible people

Primitive neuroectodermal tumor is a rare type of cancer. UCSF is conducting clinical trials to test new treatments for this disease. One trial studies the effectiveness of tipifarnib in patients with HRAS gene alterations. Another trial tests ivosidenib for patients with IDH1 mutations. A third trial tests selpercatinib for patients with activating RET gene alterations. Other trials test larotrectinib, samotolisib, ensartinib, and targeted therapy. These studies aim to find safer and better treatments for this cancer.

Showing trials for

Our lead scientists for Primitive Neuroectodermal Tumor research studies include .

Last updated: